FHD-609

Modify Date: 2025-08-24 19:56:40

FHD-609 Structure
FHD-609 structure
Common Name FHD-609
CAS Number 2676211-64-4 Molecular Weight 829.00
Density N/A Boiling Point N/A
Molecular Formula C47H56N8O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of FHD-609


FHD-609 is an inhibitor and a degrader of BRD9 (bromodomain-containing protein 9). FHD-609 targets to ncBAF, can be used for research of wide range of cancers that contain a mutation in a BAF complex subunit. FHD-609 in combination with Telomelysin or INO5401, may play a role in adrenocortical carcinoma (ACC) treatment[1][2].

 Names

Name FHD-609

 FHD-609 Biological Activity

Description FHD-609 is an inhibitor and a degrader of BRD9 (bromodomain-containing protein 9). FHD-609 targets to ncBAF, can be used for research of wide range of cancers that contain a mutation in a BAF complex subunit. FHD-609 in combination with Telomelysin or INO5401, may play a role in adrenocortical carcinoma (ACC) treatment[1][2].
Related Catalog
Target

BRD9

References

[1]. Rechberger JS, et al. Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets. Expert Opin Ther Targets. 2022 Mar;26(3):187-192.  

[2]. Hescheler DA, et al. Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options. Cancers (Basel). 2022 May 31;14(11):2721.  

 Chemical & Physical Properties

Molecular Formula C47H56N8O6
Molecular Weight 829.00
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.